Use of antimicrobial agents in consumer products

Archives of Dermatology

Volumn 138, Issue 8, 2002, Pages 1082-1086

  Tan, Litjen ^a   Nielsen, Nancy H ^a   Young, Donald C ^a   Trizna, Zoltan ^a   Dickinson, Barry ^a  

^a AMERICAN MEDICAL ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; SOAP;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CLINICAL PRACTICE; CONSUMER; DISEASE CONTROL; HEALTH CARE DELIVERY; INFECTION; LOTION; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH;

EID: 0036348258     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.138.8.1082     Document Type: Article

References (48)

1. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals
2. Microbial resistance to drug therapy: A review
3. Antibiotic resistance in bacteria: A current and future problem
4. A review of the role of antibiotic policies in the control of antibiotic resistance
5. Successful interventions for gram-negative resistance to extended-spectrum betalactam antibiotics
6. Antibiotic resistance in gram-positive bacteria: Epidemiological aspects
7. Issues in the management of resistant bacteria in long-term-care facilities
8. New intervention strategies for reducing antibiotic resistance
9. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries
10. Antiseptics and disinfectants: Activity, action, and resistance
11. Comparison of the antibacterial efficacy of 4% chlorhexidine gluconate and 1% triclosan handwash products in an acute clinical ward
12. Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin
13. Triclosan targets lipid synthesis
14. Molecular basis of triclosan activity
15. Chlorhexidine
16. The membrane destabilizing action of the antibacterial agent chlorhexidine
17. The use of antimicrobial household products: APIC position statement
18. National and regional assessment of the antibacterial soap market: A step toward determining the impact of prevalent antibacterial soaps
19. Efficacy of triclosan: Reply
20. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus
21. Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery
22. Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan
23. Handwashing in a neonatal intensive care nursery: Product acceptability and effectiveness of chlorhexidine gluconate 4% and triclosan 1%
24. Successful control of endemic MRSA in a cardiothoracic surgical unit
25. Studies on perioperative skin flora
26. Serratia marcescens contamination of antiseptic soap containing triclosan: Implications for nosocomial infection
27. Comparative effectiveness of hand-cleansing agents for removing methicillin-resistant Staphylococcus aureus from experimentally contaminated fingertips
28. Bacterial resistance and topical antimicrobial wash products
29. Bacterial resistance to disinfectants: Present knowledge and future problems
30. An assessment of triclosan susceptibility in methicillin-resistant and methicillin-sensitive Staphytococcus aureus
31. Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility
32. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli
33. Triclosan-resistant Staphylococcus aureus
34. Transferable resistance to triclosan in MRSA
35. Chlorhexidine resistance in methicillin-resistant Staphylococcus aureus or just an elevated MIC? an in vitro and in vivo assessment
36. High-level resistance to ethidium bromide and antiseptics in Staphylococcus aureus
37. Effects of the resistance plasmid R124 on the level of the OmpF outer membrane protein and on the response of Escherichia coli to environmental agents
38. Plasmids and bacterial resistance to biocides
39. Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus
40. Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: Membrane topology and identification of residues involved in substrate specificity
41. The 3′ conserved segment of integrons contains a gene associated with multidrug resistance to antiseptics and disinfectants
42. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan
43. Mechanism of triclosan inhibition of bacterial fatty acid synthesis
44. Efficacy of triclosan [reply]
45. Triclosan: A widely used biocide and its link to antibiotics
46. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: Exposure of a susceptible mutant strain to triclosan selects nfxB mutants over-expressing MexCD-OprJ